LIAISON PSA
- UID
- IMP/IVD/2019/000113_1fde04a38f8f29c96e9fb07e25fe1f24_4b4e68072f0d4a4935292b4a8b9f1857
- Device class
- Class C
- Brand name
- LIAISON fPSA
- License holder
- Diasorin Healthcare India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- In vitro assay for the quantitative determination of human prostate-specific antigen (LIAISON fPSA) in human serum and plasma (LIAISON fPSA) during the follow-up of patients with carcinoma of the prostate. The test has to be performed on the LIAISON® Analyzer family.
LIAISON PSA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000113_1fde04a38f8f29c96e9fb07e25fe1f24_4b4e68072f0d4a4935292b4a8b9f1857. This device is marketed under the brand name LIAISON fPSA. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.